{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:48:40Z","timestamp":1768636120555,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","award":["X"],"award-info":[{"award-number":["X"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF grants","award":["x"],"award-info":[{"award-number":["x"]}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"crossref","award":["X"],"award-info":[{"award-number":["X"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FORTE - Swedish Research Council","award":["X"],"award-info":[{"award-number":["X"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12985-019-1216-7","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:03:51Z","timestamp":1566471831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening"],"prefix":"10.1186","volume":"16","author":[{"given":"Inger","family":"Gustavsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riina","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Myrn\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hedlund-Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ongeziwe","family":"Taku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Enroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matts","family":"Olovsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-3355","authenticated-orcid":false,"given":"Ulf","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"1216_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ, International HPVswg. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524\u201332.","journal-title":"Lancet"},{"key":"1216_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"CJ Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124:516\u201320.","journal-title":"Int J Cancer"},{"key":"1216_CR3","volume-title":"Screening f\u00f6r livmoderhalscancer. Rekommendations och bed\u00f6mningsunderlag ISBN 978\u201391\u20137555-322-1 Report","author":"The National Board of Health and Welfare","year":"2015","unstructured":"The National Board of Health and Welfare. 2015. Screening f\u00f6r livmoderhalscancer. Rekommendations och bed\u00f6mningsunderlag ISBN 978\u201391\u20137555-322-1 Report \n                    www.socialstyrelsen.se\/publikationer2015\/2015-6-39\n                    \n                  ."},{"issue":"Suppl 3","key":"1216_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","volume":"46","author":"CJ Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof H, Heideman DA, Hesselink AT, Snijders PJ. Validation of high-risk HPV tests for primary cervical screening. J Clin Virol. 2009;46(Suppl 3):S1\u20134.","journal-title":"J Clin Virol"},{"key":"1216_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1586\/eri.10.104","volume":"8","author":"M Poljak","year":"2010","unstructured":"Poljak M, Kocjan BJ. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti-Infect Ther. 2010;8:1139\u201362.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"Suppl 5","key":"1216_CR6","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30(Suppl 5):F88\u201399.","journal-title":"Vaccine"},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","volume":"21","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015;21:817\u201326.","journal-title":"Clin Microbiol Infect"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/JCM.05552-11","volume":"49","author":"DA Heideman","year":"2011","unstructured":"Heideman DA, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJ, Daalmeijer NF, Verkuijten M, Meijer CJ, Snijders PJ. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol. 2011;49:3983\u20135.","journal-title":"J Clin Microbiol"},{"key":"1216_CR9","doi-asserted-by":"publisher","first-page":"e58153","DOI":"10.1371\/journal.pone.0058153","volume":"8","author":"B Lloveras","year":"2013","unstructured":"Lloveras B, Gomez S, Alameda F, Bellosillo B, Mojal S, Muset M, Parra M, Palomares JC, Serrano S. HPV testing by cobas HPV test in a population from Catalonia. PLoS One. 2013;8:e58153.","journal-title":"PLoS One"},{"key":"1216_CR10","doi-asserted-by":"publisher","unstructured":"Saville M, Sultana F, Malloy MJ, Velentzis LS, Caruana M, Ip ELO, Keung MHT, Canfell K, Brotherton JML, Hawkes D. Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol. 2018. \n                    https:\/\/doi.org\/10.1128\/jcm.01239-18\n                    \n                  .","DOI":"10.1128\/jcm.01239-18"},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jcv.2009.04.012","volume":"45","author":"I Gustavsson","year":"2009","unstructured":"Gustavsson I, Juko-Pecirep I, Backlund I, Wilander E, Gyllensten U. Comparison between the hybrid capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol. 2009;45:85\u20139.","journal-title":"J Clin Virol"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jcv.2011.05.006","volume":"51","author":"I Gustavsson","year":"2011","unstructured":"Gustavsson I, Sanner K, Lindell M, Strand A, Olovsson M, Wikstrom I, Wilander E, Gyllensten U. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51:255\u20138.","journal-title":"J Clin Virol"},{"key":"1216_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2015.09.016","volume":"73","author":"K Sanner","year":"2015","unstructured":"Sanner K, Wikstrom I, Gustavsson I, Wilander E, Lindberg JH, Gyllensten U, Olovsson M. Daily self-sampling for high-risk human papillomavirus (HRHPV) testing. J Clin Virol. 2015;73:1\u20137.","journal-title":"J Clin Virol"},{"key":"1216_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/bjc.2017.485","volume":"118","author":"I Gustavsson","year":"2018","unstructured":"Gustavsson I, Aarnio R, Berggrund M, Hedlund-Lindberg J, Strand AS, Sanner K, Wikstrom I, Enroth S, Olovsson M, Gyllensten U. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than pap smear cytology. Br J Cancer. 2018;118:896\u2013904.","journal-title":"Br J Cancer"},{"key":"1216_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ijc.31637","volume":"144","author":"I Gustavsson","year":"2019","unstructured":"Gustavsson I, Aarnio R, Berggrund M, Hedlund-Lindberg J, Sanner K, Wikstrom I, Enroth S, Olovsson M, Gyllensten U. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel. Int J Cancer. 2019;144:89\u201397.","journal-title":"Int J Cancer"},{"key":"1216_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jviromet.2015.12.010","volume":"229","author":"H Barth","year":"2016","unstructured":"Barth H, Morel A, Mougin C, Averous G, Legrain M, Fender M, Risch S, Fafi-Kremer S, Velten M, Oudet P, Baldauf JJ, Stoll-Keller F. Long-term storage and safe retrieval of human papillomavirus DNA using FTA elute cards. J Virol Methods. 2016;229:60\u20135.","journal-title":"J Virol Methods"},{"key":"1216_CR17","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/JCM.00285-09","volume":"47","author":"CH Lenselink","year":"2009","unstructured":"Lenselink CH, de Bie RP, van Hamont D, Bakkers JM, Quint WG, Massuger LF, Bekkers RL, Melchers WJ. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol. 2009;47:2564\u201370.","journal-title":"J Clin Microbiol"},{"key":"1216_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcv.2013.02.016","volume":"57","author":"DT Geraets","year":"2013","unstructured":"Geraets DT, van Baars R, Alonso I, Ordi J, Torne A, Melchers WJ, Meijer CJ, Quint WG. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge. J Clin Virol. 2013;57:125\u20139.","journal-title":"J Clin Virol"},{"key":"1216_CR19","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1128\/JCM.41.7.3221-3228.2003","volume":"41","author":"M Moberg","year":"2003","unstructured":"Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol. 2003;41:3221\u20138.","journal-title":"J Clin Microbiol"},{"key":"1216_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/sim.1213","volume":"22","author":"NS Tang","year":"2003","unstructured":"Tang NS, Tang ML, Chan IS. On tests of equivalence via non-unity relative risk for matched-pair design. Stat Med. 2003;22:1217\u201333.","journal-title":"Stat Med"},{"key":"1216_CR21","first-page":"119","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull BA. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. Am Stat. 1998;52:119\u201326.","journal-title":"Am Stat"},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/JCM.02116-14","volume":"53","author":"M Schiffman","year":"2015","unstructured":"Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results. J Clin Microbiol. 2015;53:52\u20139.","journal-title":"J Clin Microbiol"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pvr.2016.05.004","volume":"2","author":"J Cuzick","year":"2016","unstructured":"Cuzick J, Wheeler C. Need for expanded HPV genotyping for cervical screening. Papillomavirus Res. 2016;2:112\u20135.","journal-title":"Papillomavirus Res"},{"key":"1216_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12885-016-2518-4","volume":"16","author":"S Preisler","year":"2016","unstructured":"Preisler S, Rebolj M, Ejegod DM, Lynge E, Rygaard C, Bonde J. Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study. BMC Cancer. 2016;16:510.","journal-title":"BMC Cancer"},{"key":"1216_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059765","volume":"8","author":"S Preisler","year":"2013","unstructured":"Preisler S, Rebolj M, Untermann A, Ejegod DM, Lynge E, Rygaard C, Bonde J. Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS One. 2013;8:e59765.","journal-title":"PLoS One"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1216-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:12:37Z","timestamp":1597965157000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1216-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1216-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all study participants. Ethical approval number 2017\/088.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}